These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2468081

  • 1. Effect of osmotic protection on nucleated cell killing by C5b-9: cell death is not affected by the prevention of cell swelling.
    Kim SH, Carney DF, Papadimitriou JC, Shin ML.
    Mol Immunol; 1989 Mar; 26(3):323-31. PubMed ID: 2468081
    [Abstract] [Full Text] [Related]

  • 2. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
    Kim SH, Carney DF, Hammer CH, Shin ML.
    J Immunol; 1987 Mar 01; 138(5):1530-6. PubMed ID: 2433349
    [Abstract] [Full Text] [Related]

  • 3. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP, Imagawa DK, Dankert JR, Ramm LE.
    J Immunol; 1986 May 01; 136(9):3402-6. PubMed ID: 3514758
    [Abstract] [Full Text] [Related]

  • 4. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF, Koski CL, Shin ML.
    J Immunol; 1985 Mar 01; 134(3):1804-9. PubMed ID: 3968432
    [Abstract] [Full Text] [Related]

  • 5. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.
    Dankert JR, Esser AF.
    Biochem J; 1987 Jun 01; 244(2):393-9. PubMed ID: 3311029
    [Abstract] [Full Text] [Related]

  • 6. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF, Schmetz MA, Foulds J, Hammer CH, Frank MM, Joiner KA.
    J Immunol; 1987 Feb 01; 138(3):842-8. PubMed ID: 3100618
    [Abstract] [Full Text] [Related]

  • 7. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.
    Carney DF, Hammer CH, Shin ML.
    J Immunol; 1986 Jul 01; 137(1):263-70. PubMed ID: 3711667
    [Abstract] [Full Text] [Related]

  • 8. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 01; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 9. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML, Hänsch G, Hu VW, Nicholson-Weller A.
    J Immunol; 1986 Mar 01; 136(5):1777-82. PubMed ID: 2419414
    [Abstract] [Full Text] [Related]

  • 10. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
    Tschopp J, Podack ER, Müller-Eberhard HJ.
    J Immunol; 1985 Jan 01; 134(1):495-9. PubMed ID: 3964819
    [Abstract] [Full Text] [Related]

  • 11. Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement.
    Michaels DW, Abramovitz AS, Hammer CH, Mayer MM.
    Proc Natl Acad Sci U S A; 1976 Aug 01; 73(8):2852-6. PubMed ID: 1066698
    [Abstract] [Full Text] [Related]

  • 12. Increased susceptibility to erythrocyte C5b-9 deposition and complement-mediated lysis in chronic renal failure.
    Himmelfarb J, McMonagle E, Holbrook D, Hakim R.
    Kidney Int; 1999 Feb 01; 55(2):659-66. PubMed ID: 9987090
    [Abstract] [Full Text] [Related]

  • 13. Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
    Hänsch GM, Hammer CH, Vanguri P, Shin ML.
    Proc Natl Acad Sci U S A; 1981 Aug 01; 78(8):5118-21. PubMed ID: 6946459
    [Abstract] [Full Text] [Related]

  • 14. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1986 Apr 15; 136(8):2999-3005. PubMed ID: 3958488
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI, Packman CH, Leddy JP.
    J Clin Invest; 1983 Apr 15; 71(4):795-808. PubMed ID: 6403580
    [Abstract] [Full Text] [Related]

  • 16. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL, Monahan JB, Brickner A, Sodetz JM.
    Biochemistry; 1984 Aug 28; 23(18):4016-22. PubMed ID: 6487588
    [Abstract] [Full Text] [Related]

  • 17. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
    Sims PJ.
    Biochim Biophys Acta; 1983 Aug 10; 732(3):541-52. PubMed ID: 6871214
    [Abstract] [Full Text] [Related]

  • 18. Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9.
    Papadimitriou JC, Ramm LE, Drachenberg CB, Trump BF, Shin ML.
    J Immunol; 1991 Jul 01; 147(1):212-7. PubMed ID: 1904901
    [Abstract] [Full Text] [Related]

  • 19. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.
    Joiner KA, Schmetz MA, Sanders ME, Murray TG, Hammer CH, Dourmashkin R, Frank MM.
    Proc Natl Acad Sci U S A; 1985 Jul 01; 82(14):4808-12. PubMed ID: 3895225
    [Abstract] [Full Text] [Related]

  • 20. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
    Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ.
    Immunology; 1990 Sep 01; 71(1):1-9. PubMed ID: 1698710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.